𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of Ginkgo biloba extract EGb 761 ® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial

✍ Scribed by Gavrilova, S. I.; Preuss, U. W.; Wong, J. W. M.; Hoerr, R.; Kaschel, R.; Bachinskaya, N.

Book ID
125477364
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
232 KB
Volume
29
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a once-daily form
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial
✍ Ralf Ihl; Natalia Bachinskaya; Amos D. Korczyn; Veronika Vakhapova; Michael Trib 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

## Abstract ## Objective To test the efficacy and safety of a once‐daily formulation of EGb 761 in the treatment of patients with dementia with neuropsychiatric features. ## Methods Multi‐centre trial of 410 outpatients with mild to moderate dementia (Alzheimer's disease, vascular dementia or mi

A double-blind, placebo-controlled, rand
A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings
✍ Joseph A. Mix; W. David Crews Jr. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

There appears to be an absence of large-scaled clinical trials that have examined the efficacy of Ginkgo biloba extract on the neuropsychological functioning of cognitively intact older adults. The importance of such clinical research appears paramount in light of the plethora of products containing